Literature DB >> 22393166

Effect of genetic variation in LRRTM3 on risk of Alzheimer disease.

Christiane Reitz1, Christopher Conrad, Katherine Roszkowski, Robert S Rogers, Richard Mayeux.   

Abstract

OBJECTIVE: To explore the role of leucine-rich repeat transmembrane 3 (LRRTM3) in late-onset Alzheimer disease (AD) by independent genetic epidemiologic and functional studies.
METHODS: First, we explored associations between LRRTM3 single-nucleotide polymorphisms and AD in the National Institute on Aging Late-Onset Alzheimer's Disease case-control data set (993 patients and 884 control subjects) and a cohort of Caribbean Hispanics (549 patients and 544 controls) using single-marker and haplotype analyses. Then we explored the effect of LRRTM3 small-hairpin RNAs on amyloid precursor protein processing.
RESULTS: One single-nucleotide polymorphism in the promoter region (rs16923760; C allele: odds ratio, -0.74, P=.03), and a block of 4 single-nucleotide polymorphisms in intron 2 (rs1925608, C allele: 0.84, P=.04; rs7082306, A allele: 0.75, P=.04; rs1925609, T allele: 1.2, P=.03; and rs10997477, T allele: 0.88, P=.05) were associated with AD in the National Institute on Aging Late-Onset Alzheimer's Disease data set or the Caribbean Hispanic data set. The corresponding haplotypes were also associated with AD risk (.01 < P < .05). In addition, LRRTM3 knockdown with small-hairpin RNAs caused a significant decrease in amyloid precursor protein processing (P < .05 to P < .01) compared with the scrambled small-hairpin RNA condition.
CONCLUSIONS: These complementary findings support the notions that genetic variation in LRRTM3 is associated with AD risk and that LRRTM3 may modulate γ-secretase processing of amyloid precursor protein. Additional studies are needed to determine whether the specific alleles associated with differential risk for AD indeed confer this risk through an effect of LRRTM3 expression levels that in turn modulates amyloid precursor protein processing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22393166      PMCID: PMC3391336          DOI: 10.1001/archneurol.2011.2463

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  32 in total

Review 1.  The allelic architecture of human disease genes: common disease-common variant...or not?

Authors:  Jonathan K Pritchard; Nancy J Cox
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

Review 2.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

3.  Reconstitution of gamma-secretase activity.

Authors:  Dieter Edbauer; Edith Winkler; Joerg T Regula; Brigitte Pesold; Harald Steiner; Christian Haass
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

4.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

5.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

Authors:  N Ertekin-Taner; N Graff-Radford; L H Younkin; C Eckman; M Baker; J Adamson; J Ronald; J Blangero; M Hutton; S G Younkin
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

6.  Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

Authors:  Nilüfer Ertekin-Taner; James Ronald; Hideaki Asahara; Linda Younkin; Maria Hella; Shushant Jain; Eugene Gnida; Samuel Younkin; Daniel Fadale; Yasumasa Ohyagi; Adam Singleton; Leah Scanlin; Mariza de Andrade; Ronald Petersen; Neill Graff-Radford; Michael Hutton; Steven Younkin
Journal:  Hum Mol Genet       Date:  2003-10-14       Impact factor: 6.150

7.  Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.

Authors:  Victoria Busby; Steven Goossens; Petra Nowotny; Gillian Hamilton; Scott Smemo; Denise Harold; Dragana Turic; Luke Jehu; Amanda Myers; Meredith Womick; Daniel Woo; Danielle Compton; Lisa M Doil; Kristina M Tacey; Kit F Lau; Safa Al-Saraj; Richard Killick; Stuart Pickering-Brown; Pamela Moore; Paul Hollingworth; Nicola Archer; Catherine Foy; Sarah Walter; Corrine Lendon; Takeshi Iwatsubo; John C Morris; Joanne Norton; David Mann; Barbara Janssens; John Hardy; Michael O'Donovan; Lesley Jones; Julie Williams; Peter Holmans; Michael J Owen; Andrew Grupe; John Powell; Jolanda van Hengel; Alison Goate; Frans Van Roy; Simon Lovestone
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

8.  Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation.

Authors:  Xinwei Cao; Thomas C Südhof
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

9.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06

10.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

View more
  9 in total

1.  Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis.

Authors:  Madhu Pujar; Basavaraj Vastrad; Satish Kavatagimath; Chanabasayya Vastrad; Shivakumar Kotturshetti
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

Review 2.  Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biol Psychiatry       Date:  2013-07-25       Impact factor: 13.382

3.  Evidence of recessive Alzheimer disease loci in a Caribbean Hispanic data set: genome-wide survey of runs of homozygosity.

Authors:  Mahdi Ghani; Christine Sato; Joseph H Lee; Christiane Reitz; Danielle Moreno; Richard Mayeux; Peter St George-Hyslop; Ekaterina Rogaeva
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

Review 4.  Control of neural circuit formation by leucine-rich repeat proteins.

Authors:  Joris de Wit; Anirvan Ghosh
Journal:  Trends Neurosci       Date:  2014-08-14       Impact factor: 13.837

5.  Mutation of Elfn1 in mice causes seizures and hyperactivity.

Authors:  Jackie Dolan; Kevin J Mitchell
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

6.  Association between alcohol and Alzheimer's disease.

Authors:  Wen-Juan Huang; Xia Zhang; Wei-Wei Chen
Journal:  Exp Ther Med       Date:  2016-06-14       Impact factor: 2.447

7.  A brain proteomic signature of incipient Alzheimer's disease in young APOE ε4 carriers identifies novel drug targets.

Authors:  Jackson A Roberts; Vijay R Varma; Yang An; Sudhir Varma; Julián Candia; Giovanna Fantoni; Vinod Tiwari; Carlos Anerillas; Andrew Williamson; Atsushi Saito; Tina Loeffler; Irene Schilcher; Ruin Moaddel; Mohammed Khadeer; Jacqueline Lovett; Toshiko Tanaka; Olga Pletnikova; Juan C Troncoso; David A Bennett; Marilyn S Albert; Kaiwen Yu; Mingming Niu; Vahram Haroutunian; Bin Zhang; Junmin Peng; Deborah L Croteau; Susan M Resnick; Myriam Gorospe; Vilhelm A Bohr; Luigi Ferrucci; Madhav Thambisetty
Journal:  Sci Adv       Date:  2021-11-10       Impact factor: 14.957

Review 8.  Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer's disease and normal physiology.

Authors:  Grant Pfundstein; Alexander G Nikonenko; Vladimir Sytnyk
Journal:  Front Cell Dev Biol       Date:  2022-07-26

9.  LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD).

Authors:  Sarah Lincoln; Mariet Allen; Claire L Cox; Louise P Walker; Kimberly Malphrus; Yushi Qiu; Thuy Nguyen; Christopher Rowley; Naomi Kouri; Julia Crook; V Shane Pankratz; Samuel Younkin; Linda Younkin; Minerva Carrasquillo; Fanggeng Zou; Samer O Abdul-Hay; Wolfdieter Springer; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Zbigniew K Wszolek; Jada M Lewis; Dennis Dickson; Neill R Graff-Radford; Ronald C Petersen; Elizabeth Eckman; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.